Healthcare -
Biotechnology - NASDAQ - US
$ 128.0
0.361 %
$ 6.24 B
Market Cap
-21.33
P/E
AXSM - RESEARCH & DEVELOPMENT
Research & Development AXSM - Axsome Therapeutics, Inc.
187 M
LAST VALUE
79.68%
2 YEAR CAGR
28.38%
5 YEAR CAGR
45.90%
10 YEAR CAGR